Alla studier
AuktoriseradFas I och Fas II (Integrerad) - ÖvrigtInterventionell

The headache- and migraine-inducing effects of pitolisant in women with migraine without aura

This research is investigating a medicine called pitolisant to understand its effects, specifically if it can cause headaches or migraine attacks in women who regularly experience migraines without aura. The study compares pitolisant to a dummy pill (placebo) and other common migraine treatments like ibuprofen and sumatriptan. Scientists will observe whether women experience migraine-like attacks after taking pitolisant or the placebo. They will also measure how severe any headaches are over time and if any headache occurs, not just migraines. This is an early-stage study, combining Phase I and Phase II, to learn more about the drug's effects.

Överblick

Status
Auktoriserad
Fas
Fas I och Fas II (Integrerad) - Övrigt
Sponsor
Syddansk Universitet (University of Southern Denmark)
Inskrivningsmål
14
Starta
26 mar 2026

Vad handlar denna studie om?

This study is about a medicine called pitolisant. Researchers are trying to understand how it affects headaches and migraines in women who already have migraines but don't experience the visual changes (aura) that some people get before a migraine. They want to find out if taking pitolisant can actually cause more migraine-like headaches compared to a sugar pill (called a placebo) or other medicines often used for migraines, like ibuprofen or sumatriptan.

The main thing the scientists are looking for is whether women experience migraine attacks after taking pitolisant or the placebo. They're also interested in how strong any headaches are over time, not just the full-blown migraines. This will help them understand the drug's effects on different types of headaches.

This kind of research is really important because it helps us learn more about new medicines. By carefully comparing pitolisant to a placebo and standard treatments, doctors can get a clearer picture of its potential impact on people with migraines. This information helps healthcare professionals make informed decisions about future treatments.

Viktiga punkter

  • This study looks at how a new medicine, pitolisant, affects headaches and migraines.
  • It's for women who get migraines but don't experience auras.
  • Researchers are comparing pitolisant to a dummy pill and common migraine drugs.
  • The main goal is to see if pitolisant causes more migraine-like attacks.
  • Participation could help improve our understanding of migraine treatments.

Vem kan vara berättigad?

To be able to join this study, you must be a woman. You need to be at least 18 years old, but there's no upper age limit mentioned. Importantly, you must have migraines that do not include an 'aura' – this means you don't get the warning signs like flashing lights or blind spots before your migraine starts.

If you have headaches that are not migraines, or if your migraines always come with an aura, this study might not be suitable for you. The researchers are specifically looking for women whose migraines typically don't have this aura component.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. I am a woman.
  2. Jag är 18 år gammal eller äldre.
  3. I have migraines that do NOT include an aura (no visual changes like flashing lights before the headache).
  4. I understand I will be taking one of several possible medicines, including a dummy pill.
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part in this study, you would be asked to take a specific medicine: pitolisant, a dummy pill (placebo), ibuprofen, or sumatriptan. The study will be spread out over several visits, during which researchers will closely monitor any headaches you experience. You might need to keep a diary of your headaches. The total duration of your participation will depend on the study design, but it usually involves a series of check-ups and follow-up assessments over a period of time.

Potentiella risker och fördelar

Taking part in any study has potential benefits and risks. You might not directly benefit from taking the study medicine, but your involvement could help us learn more about migraines for others. There's a chance you might experience side effects from the trial medicines, including headaches, but these will be carefully monitored. You'll be given detailed information about all possible risks. Remember, you can choose to leave the study at any time, for any reason, without it affecting your medical care.

Platser (1)

Vissa platsangivelser är ungefärliga. Vi arbetar på att förbättra detta — vänligen kontrollera med testteamet innan du reser.
  • —
    Obekräftad
    Danmark

Vanliga frågor

What is 'migraine without aura'?

Migraine without aura means you get migraine headaches but don't have visual changes, like flashing lights, before the headache starts.

What is pitolisant?

Pitolisant is a medicine being studied to understand its effects on headaches and migraines in this research.

Vad är en 'placebo'?

A placebo is a dummy pill that looks like the real medicine but doesn't contain any active drug. It helps researchers see if the real medicine is actually having an effect.

Will I know which medicine I'm taking?

Often in these types of studies, participants don't know whether they are receiving the study drug or a placebo until the study is over. This is called 'blinding' and it helps make the results more reliable.

Hur länge kommer studien att pågå?

The information provided doesn't state the exact length, but clinical trials usually involve a period of treatment, observation, and follow-up visits.

Hur du får reda på mer

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.